Vivo Capital LLC bought a new position in shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) during the first quarter, Holdings Channel reports. The institutional investor bought 1,599,592 shares of the company’s stock, valued at approximately $26,825,000. Eiger BioPharmaceuticals accounts for 6.7% of Vivo Capital LLC’s investment portfolio, making the stock its 5th largest position. Vivo Capital […]